Skip to content
FrontierPicks

Covered

VIAV · Viavi Solutions

Conviction · Medium · more likely to lead the S&P 500 over the next three months, by a modest margin

Wrong if: a daily close below $26.30

Note written ·

How this view changed

  • · Rating raised from Low to Medium. Results, 4 November 2026: Viavi reported fiscal first-quarter 2027 revenue of $469.3 million against a $450–460 million guide and guided fiscal second-quarter revenue to $505–515 million against a $467.63 million analyst estimate.

Price against the kill line

16.8% clear of its kill line on the 13 November 2026 close.

How to read this

The red mark is the price level of the published kill line: a close through it (a weekly close, on a weekly line) would prove the research note wrong on price. The dot is where the stock closed on 13 November 2026; a dot left of the mark has closed through its line.

The scale is stretched near the line, so close calls are easy to see. More than 8% from the line, the stock reads well clear, with a hollow dot to show the figure is off the drawn scale.

The kill line is the research note's own test. The portfolio sells on business facts, not on a price. How the portfolio decides

VIAVViavi Solutions
$26.30
$30.72
16.8%well clear

Three months against the kill line

VIAV daily closes from 17 August 2026 to 13 November 2026, last $30.72, against its kill line: a daily close below $26.30. 17 August 2026: $46.2618 August 2026: $41.3719 August 2026: $38.7420 August 2026: $38.5621 August 2026: $38.9024 August 2026: $36.9525 August 2026: $37.7126 August 2026: $38.7827 August 2026: $38.4528 August 2026: $36.5431 August 2026: $36.291 September 2026: $34.812 September 2026: $34.503 September 2026: $33.634 September 2026: $34.868 September 2026: $38.759 September 2026: $39.1810 September 2026: $37.4011 September 2026: $38.7514 September 2026: $33.8215 September 2026: $33.7616 September 2026: $34.4717 September 2026: $34.7418 September 2026: $35.3621 September 2026: $36.2022 September 2026: $36.4023 September 2026: $36.4324 September 2026: $37.2325 September 2026: $40.6828 September 2026: $40.8729 September 2026: $41.8230 September 2026: $41.921 October 2026: $44.782 October 2026: $47.105 October 2026: $46.916 October 2026: $48.147 October 2026: $46.278 October 2026: $44.099 October 2026: $45.4612 October 2026: $41.7513 October 2026: $41.2814 October 2026: $38.5515 October 2026: $36.8216 October 2026: $33.3819 October 2026: $34.9820 October 2026: $34.7321 October 2026: $35.3922 October 2026: $30.3023 October 2026: $30.4526 October 2026: $31.8827 October 2026: $33.3028 October 2026: $34.4629 October 2026: $33.3230 October 2026: $29.922 November 2026: $27.803 November 2026: $30.054 November 2026: $29.385 November 2026: $26.306 November 2026: $28.479 November 2026: $31.9810 November 2026: $31.0111 November 2026: $33.0012 November 2026: $32.5413 November 2026: $30.72

Daily closes, to . Red: the kill line, a daily close below $26.30, set on 12 November 2026. The shares are down 33.6% since the close; the S&P 500 is down 2.1% over the same sessions. Figures in the note can cover a different window.

Kill line

A daily close below $26.30, the 5 November 2026 post-earnings closing low, which would erase the whole rebound and show the market rejecting the beat-and-raise report. Fiscal second-quarter revenue below the $505 million low end of the guide would also show the case failing.

Research onlyNot in the portfolio.

The portfolio's record →

Key figures from the filings · Technology

Quarter to 3 October 2026, filed 5 November 2026; valuation at the 13 November 2026 close

Revenue, latest quarter ($M)
469
Revenue, change on a year (%)
+56.9
Gross margin (%)
61.2
Operating margin (%)
17.4
Free cash flow, four quarters ($M)
153
Net cash, cash less debt ($M)
131
Price to earnings (×)
112.8
Enterprise value to sales (×)
4.4
All filed numbers

What Viavi Solutions reports to the SEC in its quarterly and annual filings. Each group states its period and filing date once; a figure dated otherwise says so. Built from the filings known on .

Results by quarter Each quarter with the day its figures were first filed, and the day of a later filing that changed them
Quarter to Revenue ($M) On a year (%) Gross margin (%) Operating margin (%)
first filed 469 +56.9 61.2 17.4
first filed 443 +52.5 59.1 13.8
first filed 407 +42.8 57.5 6.1
first filed 369 +36.4 57.0 3.1
first filed 299 +25.6 56.5 2.5
first filed 291 +15.3 56.3 5.3
Income Quarter to 3 October 2026, filed 5 November 2026
Pre-tax income ($M) 86.3
Net income ($M) four quarters: 67.0 76.0
Diluted shares, change on a year (%) against the quarter to 27 September 2025 +19.4
Cash flow Four quarters to 3 October 2026, filed 5 November 2026
Operating cash flow ($M) 188
Capital spending ($M) 34.6
Free cash flow ($M) 153
Balance sheet At 3 October 2026, filed 5 November 2026
Cash and short-term investments ($M) 529
Debt ($M) long-term debt 397
Net cash, cash less debt ($M) 131
Deferred revenue ($M) +53.1% on a year 140
Backlog, orders not yet delivered ($M) +88.4% on a year 664
Receivables ($M) 335
Inventory ($M) 174
Shareholders' equity ($M) 1,324
Valuation At the 13 November 2026 close, filed figures to 5 November 2026
Market value ($M) 7,555
Enterprise value, market value plus net debt ($M) 7,423
Enterprise value to sales (×) 4.4
Enterprise value to operating income (×) 41.4
Price to earnings (×) 112.8
Price to book value (×) 5.7
Free-cash-flow yield (%) 2.0

Short interest (FINRA, settled 15 October 2026, published 26 October 2026): 4.9% of shares outstanding sold short, 2.2 days of average trading to cover, −8.7% since the previous report.

Insiders' open-market trades SEC Form 4, by trade date, to
Window Bought Sold
90 daysfrom $0 $5.1M
12 monthsfrom $0 $57.8M

The thesis

Viavi Solutions' shares are more likely than not to beat the S&P 500 over the next three months. The 4 November 2026 fiscal first-quarter report beat its guide and lifted the outlook well above analyst estimates, and the shares remain 45.4% below their 52-week high. The fiscal second-quarter report in early February 2027 settles whether revenue reaches the guided $505–515 million.

Viavi reported revenue of $469.3 million for the quarter that ended 3 October 2026, against its own $450–460 million guide. Adjusted earnings were $0.47 per share against the $0.40–0.42 guide. Viavi guided fiscal second-quarter revenue to $505–515 million and adjusted earnings to $0.50–0.52 per share. Headlines on 4 November 2026 put analyst estimates at $467.63 million and $0.40.

The market sold the news first. The shares closed at $29.38 on 4 November 2026, the day of the after-the-close report, then fell 10.48% on 5 November 2026, according to Finviz. They rose in each of the next sessions except 10 November 2026 and closed at $33.00 on 11 November 2026. That is still below both the 50-day average of $36.44 and the 200-day average of $39.17, and the 3-month change is −23.2%.

The price already reflects deep doubt about AI infrastructure spending: the shares closed at $33.00 on 11 November 2026, 45.4% under the $60.43 intraday high of 30 April 2026, even after a guide that sits above the $467.63 million estimate.

Bullish and bearish views on Viavi Solutions Inc.

The bull case on Viavi Solutions Inc. (VIAV), in brief: the quarter beat on revenue and profit. The bear case: the shares fell on a beat-and-raise.

Bull case

  • The quarter beat on revenue and profit. Revenue of $469.3 million rose 56.9% from a year earlier and 5.9% from the prior quarter, per Viavi's 4 November 2026 release. Network and Service Enablement revenue was $376.1 million, up 74.1%.
  • The guide implies growth beyond the extra week. The quarter that ended 3 October 2026 ran 14 weeks. The fiscal second-quarter guide of $505–515 million still sits above first-quarter revenue, which answers the concern that the extra week flattered the quarter. Viavi now expects a $500 million quarterly revenue run rate in the December quarter, a goal a Finviz report on 5 November 2026 said had earlier been framed for later.
  • Margins and cash improved. Non-GAAP operating margin was 29.0%, up 1,270 basis points from a year earlier. Operating cash flow was $104.7 million and cash, short-term investments and restricted cash totalled $535.3 million, per the release.
  • Repurchases add demand for the shares. Viavi's board authorized a new $500 million repurchase program on 1 November 2026. About $18.4 million remained under the earlier $300 million plan, per the release.
  • Management reports no slowdown. Finviz reported on 5 November 2026 that management said on the earnings call it saw no sign of weaker demand, after analysts asked about the durability of AI and data-center spending.

Bear case

  • The shares fell on a beat-and-raise. The 10.48% drop on 5 November 2026 came after a report above guidance. Finviz attributed the weakness mainly to doubt about AI infrastructure spending, which is the article's reading, not a company disclosure.
  • Analysts trimmed targets after the report. UBS kept a Neutral rating and lowered its target to $33 on 6 November 2026. Needham kept a Buy rating and lowered its target to $53 on 5 November 2026.
  • Part of the margin gain did not come from operations. Finviz reported that a one-time tariff refund of about $11 million added roughly 110 basis points to operating margin. The same article noted weaker Wireless results and a seasonally lower outlook for Optical Security and Performance Products.
  • Supply sits overhead. Viavi sold shares in an offering priced at $45.00 in May 2026. The 200-day average of $39.17 and the $45.00 price both sit above the last close of $33.00.
  • Insiders have sold. Luke Scrivanich, a senior vice president, sold 35,866 shares at $36.24 on 23 September 2026 under a Rule 10b5-1 plan, per SEC Form 4. GuruFocus reported on 16 October 2026 that insiders sold $59.8 million of stock over 12 months and bought none.
  • Debt is larger than cash. The release put the net carrying value of debt at $642.5 million against $535.3 million of cash and investments. Finviz said about $245 million of convertible notes sit in short-term debt.

Price setup

The shares closed at $33.00 on 11 November 2026, up from $31.01 on 10 November 2026 and $31.98 on 9 November 2026. Closes on 6 November 2026 and 5 November 2026 were $28.47 and the post-report low, a rebound of roughly a quarter from the low within four sessions.

Three levels sit overhead, all from adjusted daily closes or the offering terms: the 50-day average of $36.44, the 200-day average of $39.17 (both as of 11 November 2026), and the $45.00 offering price. The 52-week intraday high is $60.43 on 30 April 2026. The 52-week closing low is $15.92 on 20 November 2025.

The shares gave up about 23% in three months while estimates for the next quarter rose. The 10-Q, filed 5 November 2026, and the 8-K of 4 November 2026 are the filed record of the quarter.

Catalysts ahead

  • ~4 February 2027 (est.): Fiscal second-quarter 2027 results (date not yet announced). Shows whether Viavi delivered the guided $505–515 million of revenue and the $500 million quarterly run rate that management now expects in the December quarter.

What would change the view

A daily close below $26.30, the 5 November 2026 post-earnings closing low, which would erase the whole rebound and show the market rejecting the beat-and-raise report. Fiscal second-quarter revenue below the $505 million low end of the guide would also show the case failing.

The risks this note tracks, each with what would confirm it:

  • Doubt about AI and data-center spending keeps pressuring optical and network-equipment shares regardless of Viavi's own results. Confirmed by: a large cloud customer guiding capital spending down at a quarterly report, or another sharp single-session fall in the shares without company news.
  • Viavi fails to deliver the guided December-quarter revenue. Confirmed by: fiscal second-quarter 2027 revenue below the $505 million low end of the guide at the early-February 2027 report.
  • Margin quality is weaker than the headline because of one-time items such as the tariff refund. Confirmed by: Non-GAAP operating margin in fiscal second-quarter 2027 falling below the 29.0% reported for the first quarter.
  • Supply from the May 2026 offering and the 200-day average cap any recovery. Confirmed by: rallies that fail at the 200-day average of $39.17 or below the $45.00 offering price over the next quarter.
  • Insider selling continues after the report. Confirmed by: new SEC Form 4 filings showing open-market insider sales after the 4 November 2026 report.
  • Debt maturities, including about $245 million of convertible notes cited as short-term debt, force costly refinancing or reduce buybacks. Confirmed by: a refinancing on worse terms or a reduced buyback pace disclosed in a later 10-Q.

What it trades with

Viavi trades with the optical and AI-network equipment group, and its test equipment sells into AI-related network build-outs. Analyst questions on the 4 November 2026 call about AI and data-center spending show the same sentiment that moved the shares on 5 November 2026. Viavi's fiscal calendar differs from most peers, so its report arrives after their updates have set the tone for the group.

The evidence, claim by claim (8)
  1. Viavi fiscal Q1 2027 revenue was $469.3M, up 56.9% year over year and 5.9% sequentially; non-GAAP diluted EPS was $0.47 and GAAP diluted EPS $0.29. VIAVI fiscal Q1 2027 results release, 4 November 2026 · as of
  2. Viavi guided fiscal Q2 2027 revenue to $505–515M and non-GAAP EPS to $0.50–0.52, against estimates of $467.63M and $0.40 cited in 4 November 2026 headlines. VIAVI results release and Q2 guidance headline, 4 November 2026 · as of
  3. Non-GAAP operating margin was 29.0%, up 1,270 bp year over year; operating cash flow was $104.7M; cash, short-term investments and restricted cash were $535.3M. VIAVI fiscal Q1 2027 results release, 4 November 2026 · as of
  4. Viavi's board authorized a new $500M share repurchase program on 1 November 2026; about $18.4M remained under the earlier $300M plan. VIAVI fiscal Q1 2027 results release, 4 November 2026 · as of
  5. A one-time tariff refund of about $11M contributed roughly 110 bp of Q1 operating margin; Viavi shares fell 10.48% on 5 November 2026. Finviz, 5 November 2026 · as of
  6. UBS maintained Neutral and lowered its Viavi price target to $33; Needham maintained Buy and lowered its target to $53. Benzinga headlines, 5 November 2026 and 6 November 2026 · as of
  7. Luke Scrivanich, SVP General Manager OSP, sold 35,866 shares at $36.24 on 23 September 2026 under a Rule 10b5-1 plan. SEC Form 4, filed 23 September 2026 · as of
  8. Viavi filed its 10-Q for the quarter ended 3 October 2026 and an 8-K with results on 4 November 2026. SEC EDGAR · as of

Sources

Related · shared themes

Every buy and sale, with its reason, is published in the portfolio feed. Follow the portfolio feed → Follow @frontierpicks on X